Dafna Capital Management LLC

Investment Portfolio & 13F Holdings Analysis

About

DAFNA Capital Management LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 83 holdings worth $0.4 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "EWTX",
  "ALKS",
  "RVMD",
  "ORIC",
  "GLPG",
  "BCAX",
  "BCYC",
  "ATXS",
  "ALLO",
  "RCUS",
  "GPCR",
  "IMTX",
  "TSHA",
  "ACET",
  "STOK",
  "LRMR",
  "MLYS",
  "ADCT",
  "SNDX",
  "KROS",
  "NGNE",
  "SAGE",
  "TSVT",
  "ALEC",
  "APRE",
  "BWAY",
  "PHGE",
  "AUTL",
  "NBIX",
  "KRRO",
  "KALV",
  "LXEO",
  "LCTX",
  "MDWD",
  null,
  "PVLA",
  "PRQR",
  "SPRO",
  "TELA",
  "STXS",
  "TNYA",
  "STRO",
  null,
  "IFRX",
  "PODD",
  "IDYA",
  null,
  "SPRY",
  null,
  "ATRC",
  "AQST",
  "RGLS",
  "ARAY",
  "GOSS",
  "ALGN",
  "CGEN",
  "CMPS",
  "ERAS",
  "ITOS",
  "INGN",
  "KURA",
  "URGN",
  "VKTX",
  "VYNE",
  "XENE",
  "FHTX",
  "BHVN",
  "TNDM",
  "IMVT",
  null,
  "AXGN",
  "BDTX",
  "BCRX",
  "BNTX",
  "BPMC",
  "CRDF",
  "IPSC",
  "DAWN",
  "CYTK",
  "DNLI",
  "DXCM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 83
Total Value: 352661806
Accession Number: 0001389933-25-000002
Form Type: 13F-HR
CIK: dafna-capital-management
Manager Name: Dafna-Capital-Management

Data Enrichment

94% identified

78 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

83 positions • $352,661.806K total value

83 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 1 of 5

Sort by:

78464A870

Shares:404.5K

Value:$32.8M

Stereotaxis, Inc.

STXS|85916J409

Shares:13.7M

Value:$24.1M

Revolution Medicines, Inc.

RVMD|76155X100

Shares:656.2K

Value:$23.2M

Merus N.V.

MRUS|N5749R100

Shares:461.8K

Value:$19.4M

AtriCure, Inc.

ATRC|04963C209

Shares:592.3K

Value:$19.1M

CYTOKINETICS INC

CYTK|23282W605

Shares:398.1K

Value:$16.0M

Blueprint Medicines Corp

BPMC|09627Y109

Shares:152.3K

Value:$13.5M

464287556

Shares:102.5K

Value:$13.1M

Axogen, Inc.

AXGN|05463X106

Shares:680.8K

Value:$12.6M

Ascendis Pharma A/S

ASND|04351P101

Shares:80.4K

Value:$12.5M

IDEAYA Biosciences, Inc.

IDYA|45166A102

Shares:589.3K

Value:$9.7M

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:273.7K

Value:$9.2M

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:752.4K

Value:$8.7M

NEUROCRINE BIOSCIENCES INC

NBIX|64125C109

Shares:71.6K

Value:$7.9M

Syndax Pharmaceuticals Inc

SNDX|87164F105

Shares:544.5K

Value:$6.7M

Day One Biopharmaceuticals, Inc.

DAWN|23954D109

Shares:731.4K

Value:$5.8M

TANDEM DIABETES CARE INC

TNDM|875372203

Shares:294.2K

Value:$5.6M

UroGen Pharma Ltd.

URGN|M96088105

Shares:492.5K

Value:$5.4M

Biohaven Ltd.

BHVN|G1110E107

Shares:220.2K

Value:$5.3M

Mineralys Therapeutics, Inc.

MLYS|603170101

Shares:309.2K

Value:$4.9M

Instrument	Shares		Other Manager	Value
(cusip78464A870)✕	404.5K	QoQ +1.76% (-7.0K) YoY -6.19% (-26.7K)	All Managers (Combined)	$32.8M	QoQ -8.36% (-$3.0M) YoY -19.82% (-$8.1M)
Stereotaxis, Inc.(STXScusip85916J409)	13.7M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$24.1M	QoQ -22.80% (-$7.1M) YoY -32.56% (-$11.6M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	656.2K	QoQ +3.96% (-25.0K) YoY +28.18% (+144.3K)	All Managers (Combined)	$23.2M	QoQ -15.95% (-$4.4M) YoY +40.63% (+$6.7M)
Merus N.V.(MRUScusipN5749R100)	461.8K	QoQ +2.21% (+10.0K) YoY +21.84% (+82.8K)	All Managers (Combined)	$19.4M	QoQ +2.31% (+$439.0K) YoY +13.89% (+$2.4M)
AtriCure, Inc.(ATRCcusip04963C209)	592.3K	QoQ -7.69% (-49.4K) YoY +118.52% (+321.2K)	All Managers (Combined)	$19.1M	QoQ -2.56% (-$502.8K) YoY +131.74% (+$10.9M)
CYTOKINETICS INC(CYTKcusip23282W605)	398.1K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$16.0M	QoQ -14.56% (-$2.7M) YoY -42.67% (-$11.9M)
Blueprint Medicines Corp(BPMCcusip09627Y109)	152.3K	QoQ +1.66% (+2.5K) YoY +42.61% (+45.5K)	All Managers (Combined)	$13.5M	QoQ +3.17% (+$414.5K) YoY +33.07% (+$3.3M)
(cusip464287556)✕	102.5K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$13.1M	QoQ -3.25% (-$441.8K) YoY -6.79% (-$955.3K)
Axogen, Inc.(AXGNcusip05463X106)	680.8K	QoQ -19.61% (-166.1K) YoY -27.25% (-255.1K)	All Managers (Combined)	$12.6M	QoQ -9.75% (-$1.4M) YoY +66.75% (-$5.0M)
Ascendis Pharma A/S(ASNDcusip04351P101)	80.4K	QoQ -22.21% (-23.0K) YoY -13.05% (-12.1K)	All Managers (Combined)	$12.5M	QoQ -11.93% (-$1.7M) YoY -10.35% (-$1.4M)
IDEAYA Biosciences, Inc.(IDYAcusip45166A102)	589.3K	QoQ +18.14% (-90.5K) YoY +32.03% (-143.0K)	All Managers (Combined)	$9.7M	QoQ -24.70% (-$3.2M) YoY -50.71% (-$9.9M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	273.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.2M	QoQ -14.41% (-$1.5M) YoY -22.06% (-$2.6M)
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	752.4K	QoQ -7.30% (-59.3K) YoY -6.76% (-54.6K)	All Managers (Combined)	$8.7M	QoQ +26.28% (-$1.8M) YoY -9.28% (-$888.5K)
NEUROCRINE BIOSCIENCES INC(NBIXcusip64125C109)	71.6K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$7.9M	QoQ -18.97% (-$1.9M) YoY -19.80% (-$2.0M)
Syndax Pharmaceuticals Inc(SNDXcusip87164F105)	544.5K	QoQ +0.46% (-2.5K) YoY -17.44% (-115.1K)	All Managers (Combined)	$6.7M	QoQ -6.64% (-$476.1K) YoY -57.38% (-$9.0M)
Day One Biopharmaceuticals, Inc.(DAWNcusip23954D109)	731.4K	QoQ 0.00% (-0) YoY +9.73% (-64.9K)	All Managers (Combined)	$5.8M	QoQ -37.41% (-$3.5M) YoY -47.32% (-$5.2M)
TANDEM DIABETES CARE INC(TNDMcusip875372203)	294.2K	QoQ +31.80% (-71.0K) YoY +13.94% (-36.0K)	All Managers (Combined)	$5.6M	QoQ -29.88% (-$2.4M) YoY -38.34% (-$3.5M)
UroGen Pharma Ltd.(URGNcusipM96088105)	492.5K	QoQ 0.00% (+0) YoY NEW(+492.5K)	All Managers (Combined)	$5.4M	QoQ +3.84% (+$201.9K) YoY NEW(+$5.4M)
Biohaven Ltd.(BHVNcusipG1110E107)	220.2K	QoQ 0.00% (-0) YoY +85.49% (-101.5K)	All Managers (Combined)	$5.3M	QoQ -35.63% (-$2.9M) YoY -18.46% (-$1.2M)
Mineralys Therapeutics, Inc.(MLYScusip603170101)	309.2K	QoQ +111.05% (+162.7K) YoY +243.55% (+219.2K)	All Managers (Combined)	$4.9M	QoQ +172.26% (+$3.1M) YoY +322.59% (+$3.7M)